Jesse Hatgis, DO
Interventional Pain Medicine · Tamarac, FLNPI 1154666139
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 39 manufacturers reported payments, led by Biotronik NRO, Inc. at 47.4% of the total. Among interventional pain medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,026 payments — averaging $87.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik NRO, Inc.$43K
- Elliquence, LLC$29K
- Abbott$6K
- SPR Therapeutics, Inc$4K
- Zavation Medical Products, LLC$2K
- Nevro Corp.$1K
- plus $6K from 33 others
Across 24 payments — averaging $1283.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$31K
What the payments were for
- Consulting fees$32,15036%
- Speaking & faculty fees$13,72215%
- Travel & lodging$4,4655%
- Food & beverage$39,68944%
- Education$520%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Disc-FX System$28,163
- Prospera$24,704
- SPRINT PNS System$3,795
- EXPAREL$508
- Neuromodulation-Research Only$426
- INTELLIS ADAPTIVESTIM$280
- BIOTRONIK$259
- mild Device Kit$172
- Senza Spinal Cord Stimulation System$142
- GENERAL - THERAPIES$139
- Senza$135
- Inspire Upper Airway Stimulation System$135
- Proclaim Family of SCS IPGs$120
- Neuromodulation Dspsbls and Accs$113
- LIORESAL$112
- Nalu Neurostimulation System$108
How this compares
$90,079 in reported general payments places this provider in the 95th percentile of 278 interventional pain medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 860 | $25,588 |
| BelbucaBuprenorphine Hcl | 25 | $17,132 |
| OxycontinOxycodone Hcl | 18 | $14,514 |
| Xtampza ErOxycodone Myristate | 23 | $9,182 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 398 | $8,035 |
| Buprenorphine | 46 | $7,731 |
| Oxycodone Hcl | 284 | $4,844 |
| Pregabalin | 165 | $2,473 |
| Morphine Sulfate ErMorphine Sulfate | 82 | $2,016 |
| Morphine Sulfate | 58 | $1,903 |
| Naloxone Hcl | 25 | $1,818 |
| Tramadol Hcl | 214 | $1,413 |
| Gabapentin | 117 | $1,013 |
| Celecoxib | 28 | $259 |
| Tizanidine Hcl | 38 | $249 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $712 | $26,31448 claims |
| Hikma Pharmaceuticals USABuprenorphine, Morphine Sulfate | $36 | $9,634104 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 278 interventional pain medicine providers in Florida.
Other interventional pain medicine in Tamarac
- Louis RasoJupiter$1.3M
- Ajay AntonyGainesville$1.1M
- Michael EspositoVero Beach$777K
- Nomen AzeemRiverview$650K
- Stanley GolovacMerritt Island$367K
- Sunil PanchalLutz$363K
- Robert BallPort Charlotte$246K
- Justin MannJacksonville$243K
- Giuseppe PaeseBoca Raton$180K
- Miguel de la GarzaNew Port Richey$138K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.